NEWS
Jul 24, 2026

PCAC Meeting Vote Summary

SSRP Institute
SSRP Institute

BREAKING NEWS

JULY 24, 2026 - The Pharmacy Compounding Advisory Committee (PCAC) has completed its July session, voting on several peptide bulk drug substances for potential inclusion on the FDA’s 503A Bulks List.
Recommended FOR inclusion: (Yes-No)
• BPC-157 (8–6)
• KPV (8–6)
• TB-500 (8–6)
• MOTS-c (7–5)
• Epitalon (7–4)
• Semax (8–5)
Recommended AGAINST inclusion: (Yes-No)
• DSIP (6–7)

What happens next? These votes are advisory recommendations only. The FDA will now review the committee’s recommendations alongside the scientific record, public comments, and other regulatory considerations before making a final decision on whether these bulk drug substances will be included on the 503A Bulks List.

Note: Peptide names refer to all related bulk drug substances.

Learn More

Click here to learn more about the July 2026 PCAC meetings. For future updates like this, education, training, and support, explore what the SSRP Community has to offer.

RELATED RESOURCES

Continue exploring related topics.

VIEW ALL
ARTICLE
William Seeds, MD
Sep 23, 2026
The Future of Regenerative Medicine May Begin with a Hair Follicle
William Seeds, MD Sep 23, 2026
The Future of Regenerative Medicine May Begin with a Hair Follicle
Why a Plucked Hair Follicle May Matter to the Future of Regenerative Medicine In this article, I return to a study that I discussed in a July Journal Club post. The study, published in Cells in 2024, investigated whether cells obtained from plucked, cryopreserved human hair follicles could be reprogrammed into induced pluripotent stem cells […]
READ ARTICLE
COURSE
Certification Certification
15 hrs 43 min
Peptide Therapy Certification 2026
Peptide Therapy Certification 2026
The SSRP Peptide Therapy Certification course gives clinicians, researchers, and other healthcare providers a working method for applying Cellular Medicine principles to patient care through clinical peptide therapy. Across 19 faculty-led lessons, Dr. William Seeds and SSRP faculty, including Siobhan...
19 Lessons
15 hrs 43 min
View Course
VIDEO
Cellular Medicine Mondays
Sep 21, 2026
Ep. 106 - Peptide Support After Transplant: What to Consider First
Preview only
Dissecting Protocols – Episode 106

Peptide Support After Transplant: What to Consider First

Dr. Seeds explores how to protect graft integrity and identify the right cellular targets before considering peptide support in a patient six years post liver transplant.

Preview Only — Become a member for full access
NEWS
SSRP Institute
Sep 14, 2026
In Case You Missed it: FDA Approves Mounjaro (tirzepatide) for CVD
SSRP Institute Sep 14, 2026
In Case You Missed it: FDA Approves Mounjaro (tirzepatide) for CVD
HEADLINE SCIENCE [Sept 14, 2026] – On August 28, 2026, the FDA expanded the indication for Mounjaro (tirzepatide), approving the dual GIP/GLP-1 receptor agonist to reduce the risk of major adverse cardiovascular events—including cardiovascular death, nonfatal myocardial infarction, and nonfatal stroke—in adults with type 2 diabetes at high cardiovascular risk. The decision makes tirzepatide the […]
READ NEWS
EVENT
Certification
September 10 - 11, 2027
Peptide Therapy Certification 2027
Four Seasons Resort Orlando at Walt Disney World, FL
COMING SOON
Certification
Peptide Therapy Certification 2027
COMING SOON
EVENT
World Congress
June 17 - 19, 2027
Peptide World Congress 2027
Arizona Biltmore, Phoenix, AZ
COMING SOON
World Congress
Peptide World Congress 2027
COMING SOON
EVENT
Mastermind
February 15 - 19, 2027
Fellowship Mastermind Summit 2027
Gansevoort Meatpacking NYC, New York, NY
COMING SOON
Mastermind
Fellowship Mastermind Summit 2027
COMING SOON
EVENT
Grand Rounds
December 4 - 5, 2026
Grand Rounds
Four Seasons Resort and Residences Vail
COMING SOON
Grand Rounds
Grand Rounds
COMING SOON
VIDEO
Cellular Medicine Mondays
Sep 14, 2026
Ep. 105 - Dr. Seeds’ Office Hours
Preview only
Dr. Seeds’ Office Hours – Episode 105

Dr. Seeds’ Office Hours – Episode 105

  1. Chronic wound healing through a Cellular Medicine lens, focusing on perfusion, phenotype mapping, and impaired tissue repair. (0.41)
  2. Regenerative and anti-fibrotic strategies for recurrent arthrofibrosis after ACL and meniscus reconstruction. (26:45)

Preview Only — Become a member for full access
VIDEO
Cellular Medicine Mondays
Sep 7, 2026
Ep. 104 - Phenotyping is Essential to Cellular Medicine
Preview only
Rabbit Holes – Episode 104

Phenotyping is Essential to Cellular Medicine

In this episode of Rabbit Holes, Dr. Seeds breaks down why phenotyping is essential to Cellular Medicine. Understanding the individual patient allows for more precise, personalized care instead of guessing or relying on random peptide protocols.

Preview Only — Become a member for full access

Subscribe to the SSRP Community Digest

Get the latest research and developments in the field of Cellular Medicine straight to your inbox every month.

This field is for validation purposes and should be left unchanged.